Likewise, m6A levels in rheumatoid arthritis (RA) patients’ and ischemic stroke patients’ blood were elevated relative to healthy controls, along with decreased ‘eraser’ ALKBH5 and FTO levels and increased YTHDF2 ‘reader’ levels in RA samples [145,146]. This evidence concerns the gene ALKBH5 and ischemic stroke.